LAUSR

Adams, H.J., de Klerk, J.M., Fijnheer, R., Heggelman, B.G., Dubois, S.V., Nievelstein, R.A. & Kwee, T.C. (2016) Variety in bone marrow 18FFDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation? Nuclear Medicine Communications, 37, 23–29. Ferme, C., Bastion, Y., Brice, P., Lederlin, P., Divine, M., Gabarre, J., Assouline, D., Ferrant, A., Berger, F. & Lepage, E. (1997) Prognosis of patients with advanced Hodgkin’s disease: evaluation of four prognostic models using 344 patients included in the Group d’Etudes des Lymphomes de l’Adulte Study. Cancer, 80, 1124–1133. Hasenclever, D. & Diehl, V. (1998) A prognostic score for advanced Hodgkin’s disease. International prognostic factors project on advanced Hodgkin’s disease. New England Journal of Medicine, 339, 1506–1514. Howell, S.J., Grey, M., Chang, J., Morgenstern, G.R., Cowan, R.A., Deakin, D.P. & Radford, J.A. (2002) The value of bone marrow examination in the staging of Hodgkin’s lymphoma: a review of 955 cases seen in a regional cancer centre. British Journal of Haematology, 119, 408–411. Kwee, T.C., de Klerk, J.M.H., Nix, M., Heggelman, B.G.F., Dubois, S.V. & Adams, H.J.A. (2017) Benign bone conditions that may be FDG-avid and mimic malignancy. Seminars in Nuclear Medicine, 47, 322–351. Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., Rosenberg, S.A., Coltman, C.A. & Tubiana, M. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. Journal of Clinical Oncology, 7, 1630–1636. Munker, R., Hasenclever, D., Brosteanu, O., Hiller, E. & Diehl, V. (1995) Bone marrow involvement in Hodgkin’s disease: an analysis of 135 consecutive cases. German Hodgkin’s Lymphoma Study Group. Journal of Clinical Oncology, 13, 403–409. Pedersen, M.A., Gormsen, L.C., Kamper, P., Wassberg, C., Andersen, M.D., d’Amore, A.L., Barrington, S.F., Johnson, P., Hamilton-Dutoit, S., Amini, R.M., Enblad, G., Molin, D. & d’Amore, F. (2019) Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy. British Journal of Haematology, 186, 431–439. Sovani, V., Harvey, C., Haynes, A.P., McMillan, A.K., Clark, D.M. & O’Connor, S.R. (2014) Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings. Journal of Clinical Pathology, 67, 389–395.